Our Network
We’re partnering to build a sophisticated immunotherapy industry in Australia – and beyond
Cartherics has close ties with Cell Therapies, The Peter MacCallum Cancer Centre (PMCC) Centre of Excellence in Immunotherapies, Monash University, The Australian Regenerative Medicine Institute, ToolGen Inc and a number of other institutions and companies worldwide.
In addition to its allogeneic products, Cartherics has undertaken early development of two autologous CAR-T products in collaboration with PMCC. This will undertake Phase 1 clinical trials in cutaneous T cell lymphoma and ovarian cancer.
